Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales

Jan 09 2012

• By Elizabeth Crawford

Related Content

Supplement Industry Must Step Up As Adulteration Threat Grows – FDA

Nov 28 2011

Ephedra Back On Regulatory Radar As Supplement Adulterant

Jan 02 2012

Hydroxycut Recall Eyed As Trigger For Closer Look At Supplement AERs

May 18 2009

FDA Regulatory Framework For Ephedra Ban Expected To Get Court Review

Jan 05 2004

Related Companies

Eli Lilly and Company

Additional Topics

Legal Issues Compliance OTC Drugs Consumer

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window